TerrAscend (TSNDF) Cost of Revenue (2021 - 2026)
TerrAscend's (TSNDF) quarterly Cost of Revenue came in at $30.9 million in Q1 2026, up 4.44% year-on-year from $29.6 million in Q1 2025, and down 2.3% on a QoQ basis from $31.7 million in Q4 2025.
TerrAscend (TSNDF) Cost of Revenue (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Cost of Revenue data on file, last reported at $30.9 million in Q1 2026.
- On a quarterly basis, Cost of Revenue rose 4.44% year-over-year to $30.9 million in Q1 2026; TTM through Mar 2026 was $125.6 million, a 0.93% decrease from a year earlier, with the FY2025 full-year figure at $124.2 million, down 6.03% from the prior year.
- Cost of Revenue for Q1 2026 stood at $30.9 million, down from $31.7 million in the prior quarter.
- Over the last five years, Cost of Revenue for TSNDF reached as high as $41.9 million in Q1 2024 and fell as low as -$339000.0 in Q4 2023.
- Historically, Cost of Revenue has averaged $32.5 million across 5 years, with a median of $33.0 million in 2022.
- Across the five-year window, Cost of Revenue slumped 100.89% in 2023 and surged 9338.64% in 2024, its largest moves.
- Year by year, Cost of Revenue stood at $38.2 million in 2022, then slumped by 100.89% to -$339000.0 in 2023, then jumped by 9338.64% to $31.3 million in 2024, then rose by 1.11% to $31.7 million in 2025, then decreased by 2.3% to $30.9 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $30.9 million in Q1 2026, $31.7 million in Q4 2025, and $31.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | TerrAscend | 164.05 Mn | 163.57 Mn | 34.60 Mn | 30.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.94 Mn |
| Mar 31, 2026 | 30.94 Mn |
| Dec 31, 2025 | 31.67 Mn |
| Dec 31, 2025 | 31.67 Mn |
| Sep 30, 2025 | 31.18 Mn |
| Sep 30, 2025 | 31.18 Mn |
| Jun 30, 2025 | 31.77 Mn |
| Jun 30, 2025 | 31.77 Mn |
| Mar 31, 2025 | 29.62 Mn |
| Mar 31, 2025 | 29.62 Mn |
| Dec 31, 2024 | 31.32 Mn |
| Dec 31, 2024 | 31.32 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Jun 30, 2024 | 33.84 Mn |
| Jun 30, 2024 | 33.84 Mn |
| Mar 31, 2024 | 41.90 Mn |
| Mar 31, 2024 | 41.90 Mn |
| Dec 31, 2023 | -339,000.00 |
| Dec 31, 2023 | -339,000.00 |